A serial entrepreneur in a technology and innovation focused career spanning over 30 years, John has held executive-level positions in R&D, Operations, Sales, and General Management in both the SME and MNC environment. During this period he has been a founder or co-founder of several ‘Blue Ocean’ technology start-ups, the last three of these in the life-science sector.
John has led the company from a start-up in 1997 through a U.S. merger, NASDAQ IPO, trade sale and return to a privately held company by MBO in 2008. Today Aerogen is recognized as a pioneer and the global leader, in ICU ventilator/hospital-based aerosol drug delivery. Its award-winning products are employed in over 75 countries throughout the world, helping to provide life critical interventions from the emergency department through to the NICU. Aerogen’s proprietary technology permits proteins, peptides, suspensions and solutions to be nebulized, paving the way for targeted drug delivery to the lung.
Sign up to view 0 direct reports
Get started
This person is not in any teams